Genetic Risk Factors for Pancreatic Disorders

Slides:



Advertisements
Similar presentations
Management of Chronic Pancreatitis
Advertisements

Daniela Sia, Augusto Villanueva, Scott L. Friedman, Josep M. Llovet 
Volume 143, Issue 5, Pages (November 2012)
Mesenchymal Stem Cells: Therapeutic Potential for Acute Pancreatitis
Clinical Management of Patients With Acute Pancreatitis
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Volume 133, Issue 1, Pages (July 2007)
Obesity Heats Up Adipose Tissue Lymphocytes
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
James L. Buxbaum, MD  Clinical Gastroenterology and Hepatology 
K. Lenhard Rudolph, Daniel Hartmann, Oliver G. Opitz  Gastroenterology 
Minoti V. Apte, Jeremy S. Wilson, Aurelia Lugea, Stephen J. Pandol 
Genetics and Genomics in the Practice of Medicine
Roles for Chemokines in Liver Disease
Daniela Sia, Augusto Villanueva, Scott L. Friedman, Josep M. Llovet 
Volume 154, Issue 3, Pages (February 2018)
Models of Acute and Chronic Pancreatitis
Ilya Gukovsky, Anna Gukovskaya  Gastroenterology 
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Mechanisms of Hepatic Fibrogenesis
Making Sense of HDAC2 Mutations in Colon Cancer
Intraductal Papillary Mucinous Neoplasms of the Pancreas
Volume 153, Issue 6, Pages (December 2017)
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
Volume 154, Issue 5, Pages (April 2018)
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
Volume 155, Issue 4, Pages (October 2018)
Volume 134, Issue 5, Pages (May 2008)
Volume 149, Issue 7, Pages (December 2015)
Ilya Gukovsky, Anna S. Gukovskaya  Gastroenterology 
Volume 135, Issue 4, Pages (October 2008)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
Intestinal Inflammation and Cancer
TLL1 rs Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C  Miya John, Mayada Metwally  Gastroenterology 
The Epidemiology of Pancreatitis and Pancreatic Cancer
Sibu Varghese, Pierre Lao–Sirieix, Rebecca C. Fitzgerald 
The Penetrance of Hemochromatosis: Mice to the Rescue
Volume 146, Issue 5, Pages (May 2014)
Roles for KRAS in Pancreatic Tumor Development and Progression
Management of Chronic Pancreatitis
Michael J. Williams, Andrew D. Clouston, Stuart J. Forbes 
Obesity, Inflammation, and Insulin Resistance
Covering the Cover Gastroenterology
Ilya Gukovsky, Anna S. Gukovskaya  Gastroenterology 
The Acinar Cell and Early Pancreatitis Responses
Volume 143, Issue 6, Pages e1 (December 2012)
Coffee and Colorectal Cancer: Grounds for Prevention?
Genetic Testing for Hereditary Colorectal Cancer: Challenges in Identifying, Counseling, and Managing High-Risk Patients  Elena M. Stoffel, Anu Chittenden 
Volume 150, Issue 5, Pages (May 2016)
Sharif B. Missiha, Mario Ostrowski, E. Jenny Heathcote 
William G. Couser, Richard J. Johnson  Kidney International 
Volume 155, Issue 2, Pages (August 2018)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 148, Issue 3, Pages (March 2015)
Immune Quiescence and Hepatitis B Virus: Tolerance Has Its Limits
Volume 149, Issue 6, Pages (November 2015)
Heiko Witt, Minoti V. Apte, Volker Keim, Jeremy S. Wilson 
Volume 142, Issue 4, Pages e6 (April 2012)
Covering the Cover Gastroenterology
Hunting for Celiac Disease Genes
Volume 133, Issue 1, Pages (July 2007)
Analyses of Hospital Administrative Data That Use Diagnosis Codes Overestimate the Cases of Acute Pancreatitis  Shreyas Saligram, David Lo, Melissa Saul,
A Novel Role for the Fibroblast Growth Factor 21 in Acute Pancreatitis
Volume 139, Issue 6, Pages e1 (December 2010)
Early Detection of Pancreatic Cancer: Opportunities and Challenges
Risk of Pancreatitis in Patients With Celiac Disease: Is Autoimmune Pancreatitis a Biologically Plausible Mechanism?  John S. Leeds, David S. Sanders 
Volume 138, Issue 6, Pages (May 2010)
Volume 143, Issue 5, Pages (November 2012)
Digesting New Information About the Role of Trypsin in Pancreatitis
Presentation transcript:

Genetic Risk Factors for Pancreatic Disorders David C. Whitcomb  Gastroenterology  Volume 144, Issue 6, Pages 1292-1302 (May 2013) DOI: 10.1053/j.gastro.2013.01.069 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 Progression of pancreatic injury. CP is illustrated as a syndrome that develops over time (left to right). (A) Individuals may live for years with multiple susceptibility factors. Patients at very high risk may be candidates for prevention strategies, such as avoiding alcohol. (B) When a stochastic event leads to pancreatic injury, it initiates the Sentinel Acute Pancreatitis Event (SAPE) with intrapancreatic immune system activation. Management includes identification of actionable risk and prevention of RAP. (C) Factors such as alcohol, smoking, and genetic mutations or presently unidentified factors affect the specialized cells of the pancreas and infiltrating cells to cause various complications. Research efforts are focusing on identifying risk, mechanisms, and biomarkers of the progression pathways. Gastroenterology 2013 144, 1292-1302DOI: (10.1053/j.gastro.2013.01.069) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Genetic and environmental factors that affect acinar cells or ducts. Premature trypsin activation may occur in the acinar cell or in the duct to initiate pancreatitis. The majority of known risk factors can be classified as primarily affecting the acinar cells or pancreatic ducts. Understanding the site of likely trypsin activation and mechanism may guide preventative strategies in the future. IPMN, intraductal papillary mucinous neoplasm. Reprinted with permission from Solomon and Whitcomb.76 Gastroenterology 2013 144, 1292-1302DOI: (10.1053/j.gastro.2013.01.069) Copyright © 2013 AGA Institute Terms and Conditions

Figure 3 Risks of RAP and CP. Data collected in population-based analysis of 7456 residents of Allegheny County, Pennsylvania, following their first (sentinel) episode of AP. (A) Risk of developing RAP based on etiology. (B) Risk of CP based on the presence or absence of documented RAP. Reprinted with permission from Yadav et al.84 Gastroenterology 2013 144, 1292-1302DOI: (10.1053/j.gastro.2013.01.069) Copyright © 2013 AGA Institute Terms and Conditions

Figure 4 Factors contributing to the development of pancreatitis. The first hit increases susceptibility to injury, whereas the second hit affects the immune response (and includes leukocytes, such as M2 macrophages) to promote stellate cell–associated fibrosis. Alcohol could injure the pancreas via its effects on acinar cells, but it is probably more important in the second group as a modifier of the immune response. For example, it could promote a Th17-cell response or act directly on stellate cells (dashed lines). Altered trypsin functions in acinar cells or ducts could also initiate disease. In either case, similar second hit factors then contribute to the development of fibrosis (via variants in SPINK1 and/or CTRC). Severe AP involves widespread pancreatic necrosis (approximately 90% of tissue), which leads directly to scarring and fibrosis in the recovery phase. Obese patients could have areas of adipose tissue that contain local necrosis of acinar tissue, which has been linked to lipotoxicity. Progressive fibrosis could occur in patients with RAP. Other pathways include AIP, in which the pathway to fibrosis is less well understood. Gastroenterology 2013 144, 1292-1302DOI: (10.1053/j.gastro.2013.01.069) Copyright © 2013 AGA Institute Terms and Conditions

David C. Whitcomb Gastroenterology 2013 144, 1292-1302DOI: (10.1053/j.gastro.2013.01.069) Copyright © 2013 AGA Institute Terms and Conditions